Effects of the Physical Fitness on Serum Klotho Levels in Healthy Population (CoFiKSa)

July 22, 2019 updated by: Margarita Perez, Universidad Europea de Madrid

Effects of the Physical Fitness on Serum Klotho Levels in Healthy Population: Response and Adaptation

Exercise program in serum Klotho levels

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

This study aims to analiyze the effects of acute exercise in serum Klotho levels attending physical fitness in healthy population

Study Type

Interventional

Enrollment (Actual)

85

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Spain
    • Villaviciosa De Odon
      • Madrid, Villaviciosa De Odon, Spain, 28670
        • Escuela de Doctorado e Invesitgacion, Universidad Europea

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 45 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • healthy people between 20 and 45 years old

Exclusion Criteria:

  • acute and chronic disease, people who take medication and supplements, smoker.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Single Group Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Plyometric
Effects of plyometric acute exercise
Other: plyometric exercise
acute plyometric exercise
Experimental: Aerobic
Effects of aerobic acute exercise
Other: Aerobic exercise
acute aerobic exercise

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in serum Klotho levels
Time Frame: Baseline and one hour
Change from baseline to acute exercise session
Baseline and one hour

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Cardiorespiratory Fitness VO2max
Time Frame: Baseline
For this Variable All people Will perform a exercise test on treadmill (Tecnhogym run race 1400HC; Gambettola, Italy), in this way we determinate the VO2max. Through the modifies Balke protocol. The gas Exchange data Will measured breath by breath using open circuit spirometry and specific face mask for Fitmate, Cosmed; Vmax 29C, Sensormedics machine.
Baseline
Change in Body Composition
Time Frame: Baseline
The age in years; height in centimeters (tallimeter Ano Sayol SL, Barcelona, Spain); weight in kilograms (Inbody 720, Microcaya) and we can derive from this data the variable of Body Mass Index (BMI) calculated as weight (kg)/height (m2).
Baseline
Change in Body Composition, Body muscle mass Index
Time Frame: Baseline
For determinate this variable of the body composition will be use a Dual Densitometry X-Ray (DXA) (Hologic QDR Discovery, Bedford, MA, USA)
Baseline
Change in Body Composition, % of Fat Mass
Time Frame: Baseline
For determinate this variable of the body composition will be use a Dual Densitometry X-Ray (DXA) (Hologic QDR Discovery, Bedford, MA, USA)
Baseline
Change in Body Composition, Total Muscle Mass
Time Frame: Baseline
For determinate this variable of the body composition will be use a Dual Densitometry X-Ray (DXA) (Hologic QDR Discovery, Bedford, MA, USA)
Baseline
Change in Body Composition, Visceral Fat Index.
Time Frame: Baseline
For determinate this variable of the body composition will be use a Dual Densitometry X-Ray (DXA) (Hologic QDR Discovery, Bedford, MA, USA). This value is really important to determine a cardiovascular risk.
Baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Universidad Europea de Madrid

Investigators

  • Principal Investigator: Valentin Fernandez Elias, Ph, Universidad Europea de Madrid

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 21, 2018

Primary Completion (Actual)

October 30, 2018

Study Completion (Actual)

March 26, 2019

Study Registration Dates

First Submitted

March 19, 2018

First Submitted That Met QC Criteria

April 16, 2018

First Posted (Actual)

April 26, 2018

Study Record Updates

Last Update Posted (Actual)

July 23, 2019

Last Update Submitted That Met QC Criteria

July 22, 2019

Last Verified

July 1, 2019

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • Ref 47/764390.09/17

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy Population

Clinical Trials on plyometric exercise

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Egypt

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe